Brian Buck

Has grant

Associate Professor

University of Alberta Hospital

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brian Buck is an Associate Professor at the University of Alberta Hospital, Canada. His research focuses on acute ischemic stroke, including thrombolysis effectiveness, clinical trial outcomes, and neurological recovery. His recent publications address topics such as the impact of treatment methods on cognitive outcomes and the use of automatic matching algorithms for stroke trial participants.

Recent Grants

Grant: Close

INTERRAcT: Thrombus characteristics for predicting Reperfusion with Alteplase compared to Tenecteplase

Open Date: 2021-04-01

Close Date: 2024-03-31

Grant: Close

Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke: QuICR & OPTIMISE Registry based Pragmatic Randomized Controlled Trial

Open Date: 2019-10-01

Close Date: 2022-09-30

Grant: Close

SECRET: Study of rivaroxaban for CeREbral venous Thrombosis

Open Date: 2018-04-01

Close Date: 2020-03-31

Grant: Close

Carotid atheroma treated with aggressive lipid management assessed by magnetic resonance imaging (CALM-MR).

Open Date: 2006-07-01

Close Date: 2008-06-01

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (16)

Rick Swartz

Associate Professor

University of Toronto

CANADA

Brian Buck

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (24)

Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion

Faster Thrombolysis Is Associated With Improved Cognitive Outcomes in Patients With Acute Ischemic Stroke Treated With Alteplase and Tenecteplase: A Substudy of the AcT Trial

Predictors and Outcomes of ASPECTS decay during inter-facility transfers in patients with large vessel occlusion

Automatic Matching Algorithms to Identify Eligible Participants for Stroke Trials: A Proof-of-Concept Study

Impact of Clinical Trial Enrollment on Thrombolysis Workflow in a Mobile Stroke Unit: Results from the AcT Trial

Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke Treatment

Impact of Brain Frailty on Clinical Presentation and Neurologic Recovery in Acute Ischemic Stroke Patients Undergoing Thrombectomy

Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 Trial

Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial

Comparison of Noncontrast Computed Tomography, Multiphase Computed Tomography Angiography, and Computed Tomography Perfusion to Assess Infarct Growth Rate in Acute Stroke

Workflow and Short-Term Functional Outcomes in Simultaneous Acute Code Stroke Activation and Stroke Reperfusion Therapy

Prevalence of “Ghost Infarct Core” after Endovascular Thrombectomy

Infarct Evolution on MR-DWI After Thrombectomy in Acute Stroke Patients Randomized to Nerinetide or Placebo

Effect of incomplete reperfusion patterns on clinical outcome: insights from the ESCAPE-NA1 trial

Advances in the management of acute ischemic stroke

Direct to Angiosuite in Acute Stroke with Mobile Stroke Unit

Risk of Hemorrhagic Transformation with Early Use of Direct Oral Anticoagulants after Acute Ischemic Stroke: A Pooled Analysis of Prospective Studies and Randomized Trials

Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial

Poor Cortical Venous Opacification on Baseline Computed Tomography Angiography Predicts Parenchymal Hemorrhage After Thrombectomy

Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic Stroke

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.

Predictors and clinical impact of infarct progression rate in the ESCAPE-NA1 trial

Return on Investment in Endovascular Care: The Case of Endovascular Reperfusion Alberta

Pre-hospital triage of suspected acute stroke patients in a mobile stroke unit in the rural Alberta.

Collaborators (16)

Rick Swartz

Michael Kelly

Robert Joseph Sarmiento

Houman Khosravani

Michael D. Hill

Jennifer McCombe

Radhika Nair

Mohammed Almekhlafi

Thalia Field

William Burgin

Oh Young Bang

Shahid Nimjee

Shelagh B Coutts

Ashfaq Shuaib

Mahesh Kate

Philip Choi

Make your next move.